AGP Picks
View all

Health Times of Rhode Island: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times of Rhode Island.

Press releases published on July 30, 2026

Telix H1 2026 Results: Investor Webcast Notification
Laguna Treatment Center Now Offers Virtual Outpatient Services for those Struggling with Addiction
ColestZen Launch 2026 - Healthy Cholesterol Support Formula With 18 Ingredients In (US, UK, CA, AU).ColestZen Capsule Benefits and Supplement Facts
Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma
Sanuwave Will Host a Conference Call on August 7, 2026 at 8:30 AM (ET) to Present Q2 2026 Financial Results
SodaSlim Official Launch 2026 Natural Weight Loss Capsules For metabolic and appetite support in USA. Soda Slim Highlights Ingredient and Supplement Facts
DBV Technologies Announces Sale of Approximately $50 Million of ADSs Through Its At-The-Market (ATM) Program on Nasdaq
DBV Technologies annonce le placement d’ADS pour un montant d’environ 50 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
Seer Confirms Receipt of Further Revised Unsolicited Acquisition Proposals From Radoff-JEC Group and From Omid Farokhzad, M.D.
FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026
Cellectis to Report Second Quarter Financial Results on August 6, 2026
Cellectis publiera ses résultats financiers du deuxième trimestre jeudi 6 août 2026
STERIS Raises Dividend to $0.69 per share
Voting Rights and Shares Capital of the Company
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
CooperCompanies Announces Release Date for Third Quarter 2026
DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound
GenomOncology Announces Integrated End-to-End Workflow Using PacBio’s Long-Read Whole-Genome Sequencing Technology in Oncology
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Times of Rhode Island

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.